These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18062409)

  • 1. Metabolic fate of the antipsychotic agent, mazapertine, in man--API-MS and MS/MS identification of urinary metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2007; 32(3):171-6. PubMed ID: 18062409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):279-86. PubMed ID: 14743969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of the antipsychotic agent, mazapertine, in dog--mass spectral characterization and identification of metabolites.
    Wu WN; McKown LA; Takacs AR; Jones WJ; Reitz AB
    Xenobiotica; 1999 May; 29(5):453-66. PubMed ID: 10379984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats.
    Caldwell GW; Wu WN; McKown LA; Diane Gauthier A; Masucci JA; Jones WJ; Leo GC; Reitz AB
    J Pharm Biomed Anal; 2006 May; 41(2):500-9. PubMed ID: 16386397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites.
    Wu WN; McKown LA; Moyer MD; Reitz AB
    J Pharm Biomed Anal; 2000 Dec; 24(2):307-16. PubMed ID: 11130209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the new alpha-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):113-20. PubMed ID: 16010870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):257-62. PubMed ID: 15726887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic biotransformation of the new calcium-mimetic agent, RWJ-68025, in the rat and in man--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Rybczynski PJ; Demarest K
    J Pharm Pharmacol; 2003 May; 55(5):631-7. PubMed ID: 12831505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of primary metabolites of ranolazine in dog urine by LC-MS(n)].
    Tang JY; Wang W; Li L; Zhang CG; Wang DM; Sun L
    Yao Xue Xue Bao; 2012 Aug; 47(8):1031-8. PubMed ID: 23162900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men.
    Kleinbloesem CH; Jaquet-Müller F; al-Hamdan Y; Baldauf C; Gisclon L; Wesnes K; Curtin CR; Stubbs RJ; Walker SA; Brunner-Ferber F
    Clin Pharmacol Ther; 1996 Jun; 59(6):675-85. PubMed ID: 8681493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites.
    Wu WN; McKown LA; Liao S
    Xenobiotica; 2002 May; 32(5):411-25. PubMed ID: 12065063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro metabolism of thalicarpine, an aporphine-benzyltetrahydroisoquinoline alkaloid, in the rat. API-MS/MS identification of thalicarpine and metabolites.
    Wu WN; McKown LA
    J Pharm Biomed Anal; 2002 Aug; 30(1):141-50. PubMed ID: 12151074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
    Kassahun K; Mattiuz E; Nyhart E; Obermeyer B; Gillespie T; Murphy A; Goodwin RM; Tupper D; Callaghan JT; Lemberger L
    Drug Metab Dispos; 1997 Jan; 25(1):81-93. PubMed ID: 9010634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    J Pharm Biomed Anal; 2003 Feb; 31(1):95-102. PubMed ID: 12560053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of pantoprazole involving conjugation with glutathione in rats.
    Zhong D; Xie Z; Chen X
    J Pharm Pharmacol; 2005 Mar; 57(3):341-9. PubMed ID: 15807990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the alpha-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 fractions -API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):105-11. PubMed ID: 16010869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.